Richard Silverman | Novel GABA aminotransferase and ornithine aminotransferase inactivators as potential new treatments for epilepsy, pain and hepatocellular carcinoma episode artwork

EPISODE · Sep 12, 2025 · 42 MIN

Richard Silverman | Novel GABA aminotransferase and ornithine aminotransferase inactivators as potential new treatments for epilepsy, pain and hepatocellular carcinoma

from Pipettes and Politics · host ASBMB

The rationale, design, and mechanism of GABA aminotransferase and ornithine aminotransferase inactivators will be presented as well as in vitro and in vivo efficacy and pharmacokinetic results, toxicology studies, and a clinical trial with one of the inactivators.

Episode metadata supplied by the publisher feed · Published Sep 12, 2025

Embed this episode

Ready to play

Richard Silverman | Novel GABA aminotransferase and ornithine aminotransferase inactivators as potential new treatments for epilepsy, pain and hepatocellular carcinoma

0:00 42:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pipettes and Politics?

This episode is 42 minutes long.

When was this Pipettes and Politics episode published?

This episode was published on September 12, 2025.

Can I download this Pipettes and Politics episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!